Found: 19
Select item for more details and to access through your institution.
Acknowledgement to Referees.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 553, doi. 10.1007/s40801-024-00466-7
- Publication type:
- Article
A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 691, doi. 10.1007/s40801-024-00465-8
- By:
- Publication type:
- Article
Comparison of the Safety of Aspirin Monotherapy and Aspirin and P2Y12 Inhibitor Combination Therapy in Patients Post Coil Embolization During Admission: A Cross-Sectional Study Using a Nationwide Inpatient Database.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 679, doi. 10.1007/s40801-024-00464-9
- By:
- Publication type:
- Article
A Pilot Study on the Collection of Adverse Event Data from the Patient Using an Electronic Platform in a Cancer Clinical Trial Unit.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 725, doi. 10.1007/s40801-024-00461-y
- By:
- Publication type:
- Article
Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 557, doi. 10.1007/s40801-024-00460-z
- By:
- Publication type:
- Article
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 669, doi. 10.1007/s40801-024-00454-x
- By:
- Publication type:
- Article
Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 701, doi. 10.1007/s40801-024-00458-7
- By:
- Publication type:
- Article
US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 593, doi. 10.1007/s40801-024-00457-8
- By:
- Publication type:
- Article
Assessing the Costs of Intravenous Push Waste in Intraoperative Areas Through Observation: A Multi-site Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 635, doi. 10.1007/s40801-024-00456-9
- By:
- Publication type:
- Article
Psychotropic Drug Use and Associated Factors Among Acutely Admitted Older People: A Cross-Sectional Study of a Clinical Sample.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 627, doi. 10.1007/s40801-024-00455-w
- By:
- Publication type:
- Article
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 573, doi. 10.1007/s40801-024-00459-6
- By:
- Publication type:
- Article
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 565, doi. 10.1007/s40801-024-00453-y
- By:
- Publication type:
- Article
Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 711, doi. 10.1007/s40801-024-00452-z
- By:
- Publication type:
- Article
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 735, doi. 10.1007/s40801-024-00441-2
- By:
- Publication type:
- Article
Prescription Patterns of Inducers and Inhibitors of Cytochrome P450 and Their Potential Drug Interactions in the Real World: A Cross-Sectional Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 617, doi. 10.1007/s40801-024-00450-1
- By:
- Publication type:
- Article
Prognostic Factors in Japanese EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Real-World Single-Center Retrospective Cohort Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 603, doi. 10.1007/s40801-024-00449-8
- By:
- Publication type:
- Article
Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Real World Evidence of User Experience with Microenemas for Relief of Constipation.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 659, doi. 10.1007/s40801-024-00444-z
- By:
- Publication type:
- Article
Older Adults' Use of Cannabis and Attitudes Around Disclosing Medical Cannabis Use to Their Healthcare Providers in California: A Mixed Methods Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 4, p. 647, doi. 10.1007/s40801-024-00451-0
- By:
- Publication type:
- Article